{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:46:54Z","timestamp":1777556814404,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:00Z","timestamp":1598140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:00Z","timestamp":1598140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100016982","name":"Rising Tide Foundation","doi-asserted-by":"crossref","award":["CCR-17-300"],"award-info":[{"award-number":["CCR-17-300"]}],"id":[{"id":"10.13039\/501100016982","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K07CA218167-03"],"award-info":[{"award-number":["5K07CA218167-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K12HD001441"],"award-info":[{"award-number":["5K12HD001441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00520-020-05697-2","type":"journal-article","created":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T03:24:11Z","timestamp":1598153051000},"page":"2007-2014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-1457","authenticated-orcid":false,"given":"Zev M.","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald L.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Quillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza M.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,23]]},"reference":[{"key":"5697_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.seminoncol.2011.03.014","volume":"38","author":"MC Janelsins","year":"2011","unstructured":"Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38:431\u2013438. https:\/\/doi.org\/10.1053\/j.seminoncol.2011.03.014","journal-title":"Semin Oncol"},{"key":"5697_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamaoncol.2017.5674","volume":"4","author":"TT Hshieh","year":"2018","unstructured":"Hshieh TT, Jung WF, Grande LJ, Chen J, Stone RM, Soiffer RJ, Driver JA, Abel GA (2018) Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncol 4:686\u2013693","journal-title":"JAMA Oncol"},{"key":"5697_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neubiorev.2017.10.028","volume":"83","author":"LJ Bernstein","year":"2017","unstructured":"Bernstein LJ, McCreath GA, Komeylian Z, Rich JB (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis. Neurosci Biobehav Rev 83:417\u2013428","journal-title":"Neurosci Biobehav Rev"},{"key":"5697_CR4","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","volume":"30","author":"TA Ahles","year":"2012","unstructured":"Ahles TA, Root JC, Ryan EL (2012) Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 30:3675\u20133686. https:\/\/doi.org\/10.1200\/JCO.2012.43.0116","journal-title":"J Clin Oncol"},{"key":"5697_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1176\/ajp.140.6.734","volume":"140","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P et al (1983) Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140:734\u2013739. https:\/\/doi.org\/10.1176\/ajp.140.6.734","journal-title":"Am J Psychiatry"},{"key":"5697_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40:812","journal-title":"Arch Gen Psychiatry"},{"key":"5697_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"5697_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00520-008-0431-3","volume":"16","author":"RA Olson","year":"2008","unstructured":"Olson RA, Chhanabhai T, McKenzie M (2008) Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer 16:1273\u20131278. https:\/\/doi.org\/10.1007\/s00520-008-0431-3","journal-title":"Support Care Cancer"},{"key":"5697_CR9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, Schmieder L, Ansari R, Tew WP, Weckstein D, Kirshner J, Togawa K, Hansen K, Katheria V, Stone R, Galinsky I, Postiglione J, Cohen HJ (2011) Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29:1290\u20131296. https:\/\/doi.org\/10.1200\/JCO.2010.30.6985","journal-title":"J Clin Oncol"},{"key":"5697_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jgo.2019.11.007","volume":"11","author":"TT Koll","year":"2020","unstructured":"Koll TT, Sheese AN, Semin J, Ernst W, High R, Wildes TM, Fisher A, Murman DL (2020) Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing. J Geriatr Oncol 11:297\u2013303. https:\/\/doi.org\/10.1016\/j.jgo.2019.11.007","journal-title":"J Geriatr Oncol"},{"key":"5697_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoto.2017.2014","volume":"143","author":"AM Williams","year":"2017","unstructured":"Williams AM, Lindholm J, Cook D, Siddiqui F, Ghanem TA, Chang SS (2017) Association between cognitive function and quality of life in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 143:1228\u20131235. https:\/\/doi.org\/10.1001\/jamaoto.2017.2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5697_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/arclin\/acp060","volume":"24","author":"MA Friedman","year":"2009","unstructured":"Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA (2009) Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Arch Clin Neuropsychol 24:689\u2013698. https:\/\/doi.org\/10.1093\/arclin\/acp060","journal-title":"Arch Clin Neuropsychol"},{"key":"5697_CR13","first-page":"S291","volume":"24","author":"JC Root","year":"2018","unstructured":"Root JC, Rocha-Cadman X, Kasven-Gonzalez N et al (2018) Pre-transplant cognitive dysfunction in hematologic cancers, predictors and associated outcomes. Biol Blood Marrow Transplant 24:S291\u2013S459","journal-title":"Biol Blood Marrow Transplant"},{"key":"5697_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41409-018-0151-3","volume":"53","author":"RJ Lin","year":"2018","unstructured":"Lin RJ, Shahrokni A, Dahi PB, Jakubowski AA, Devlin SM, Maloy MA, Robinson KS, Perales MA, Shah GL, Korc-Grodzicki B, Giralt SA (2018) Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience. Bone Marrow Transplant 53:1184\u20131187. https:\/\/doi.org\/10.1038\/s41409-018-0151-3","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/S1355617716000126","volume":"22","author":"C Yao","year":"2016","unstructured":"Yao C, Rich JB, Tannock IF, Seruga B, Tirona K, Bernstein LJ (2016) Pretreatment differences in intraindividual variability in reaction time between women diagnosed with breast cancer and healthy controls. J Int Neuropsychol Soc 22:530\u2013539. https:\/\/doi.org\/10.1017\/S1355617716000126","journal-title":"J Int Neuropsychol Soc"},{"key":"5697_CR16","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1200\/JCO.2015.63.0905","volume":"33","author":"JL Vardy","year":"2015","unstructured":"Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF (2015) Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol 33:4085\u20134092. https:\/\/doi.org\/10.1200\/JCO.2015.63.0905","journal-title":"J Clin Oncol"},{"key":"5697_CR17","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/hed.25198","volume":"40","author":"LJ Bernstein","year":"2018","unstructured":"Bernstein LJ, Pond GR, Gan HK, Tirona K, Chan KK, Hope A, Kim J, Chen EX, Siu LL, Razak ARA (2018) Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort. Head Neck 40:2029\u20132042. https:\/\/doi.org\/10.1002\/hed.25198","journal-title":"Head Neck"},{"key":"5697_CR18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/pon.3214","volume":"22","author":"MJJ Pullens","year":"2013","unstructured":"Pullens MJJ, De Vries J, Van Warmerdam LJC et al (2013) Chemotherapy and cognitive complaints in women with breast cancer. Psychooncology 22:1783\u20131789. https:\/\/doi.org\/10.1002\/pon.3214","journal-title":"Psychooncology"},{"key":"5697_CR19","doi-asserted-by":"publisher","first-page":"djv099","DOI":"10.1093\/jnci\/djv099","volume":"107","author":"K Hermelink","year":"2015","unstructured":"Hermelink K, Voigt V, Kaste J et al (2015) Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst 107:djv099. https:\/\/doi.org\/10.1093\/jnci\/djv099","journal-title":"J Natl Cancer Inst"},{"key":"5697_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/pon.4200","volume":"26","author":"M Lycke","year":"2017","unstructured":"Lycke M, Pottel L, Pottel H, Ketelaars L, Stellamans K, van Eygen K, Vergauwe P, Werbrouck P, Goethals L, Schofield P, Boterberg T, Debruyne PR (2017) Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment. Psychooncology 26:632\u2013639. https:\/\/doi.org\/10.1002\/pon.4200","journal-title":"Psychooncology"},{"key":"5697_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","volume":"53","author":"D Buchbinder","year":"2018","unstructured":"Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE (2018) Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 53:535\u2013555","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR22","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","volume":"29","author":"KL Syrjala","year":"2011","unstructured":"Syrjala KL, Artherholt SB, Kurland BF, Langer SL, Roth-Roemer S, Elrod JAB, Dikmen S (2011) Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol 29:2397\u20132404. https:\/\/doi.org\/10.1200\/JCO.2010.33.9119","journal-title":"J Clin Oncol"},{"key":"5697_CR23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/cncr.22962","volume":"110","author":"SR Jacobs","year":"2007","unstructured":"Jacobs SR, Small BJ, Booth-Jones M, Jacobsen PB, Fields KK (2007) Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer 110:1560\u20131567. https:\/\/doi.org\/10.1002\/cncr.22962","journal-title":"Cancer"},{"key":"5697_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41409-019-0746-3","volume":"55","author":"SJ Mayo","year":"2020","unstructured":"Mayo SJ, Messner HA, Rourke SB, Howell D, Victor JC, Lipton JH, Kuruvilla J, Gutpa V, Kim DDH, Michelis FV, Metcalfe K (2020) Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55:918\u2013928. https:\/\/doi.org\/10.1038\/s41409-019-0746-3","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR25","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1002\/cncr.26645","volume":"118","author":"HSL Jim","year":"2012","unstructured":"Jim HSL, Small B, Hartman S, Franzen J, Millay S, Phillips K, Jacobsen PB, Booth-Jones M, Pidala J (2012) Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer 118:3407\u20133416. https:\/\/doi.org\/10.1002\/cncr.26645","journal-title":"Cancer"},{"key":"5697_CR26","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.bbmt.2017.08.006","volume":"23","author":"AI Hoogland","year":"2017","unstructured":"Hoogland AI, Nelson AM, Small BJ, Hyland KA, Gonzalez BD, Booth-Jones M, Anasetti C, Jacobsen PB, Jim HSL (2017) The role of age in neurocognitive functioning among adult allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 23:1974\u20131979. https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"5697_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/pon.3159","volume":"22","author":"A Scherwath","year":"2013","unstructured":"Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A, Kunze S, Balck F, Bornh\u00e4user M, Ehninger G, Dolan K, Gramatzki M, Kolb HJ, Heu\u00dfner P, Wilhelm H, Beelen DW, Schulz-Kindermann F, Zander AR, Koch U, Mehnert A (2013) Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology 22:1509\u20131516. https:\/\/doi.org\/10.1002\/pon.3159","journal-title":"Psychooncology"},{"key":"5697_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radonc.2018.09.012","volume":"131","author":"LJ McDowell","year":"2019","unstructured":"McDowell LJ, Ringash J, Xu W et al (2019) A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. Radiother Oncol 131:179\u2013185. https:\/\/doi.org\/10.1016\/j.radonc.2018.09.012","journal-title":"Radiother Oncol"},{"key":"5697_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"5697_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","volume":"19","author":"RP McQuellon","year":"1997","unstructured":"McQuellon RP, Russell GB, Cella DF et al (1997) Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 19:357\u2013368. https:\/\/doi.org\/10.1038\/sj.bmt.1700672","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR31","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912\u20132919","journal-title":"Blood"},{"key":"5697_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1200\/JCO.2017.74.2270","volume":"36","author":"N Sharafeldin","year":"2018","unstructured":"Sharafeldin N, Bosworth A, Patel SK, Chen Y, Morse E, Mather M, Sun C, Francisco L, Forman SJ, Wong FL, Bhatia S (2018) Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study. J Clin Oncol 36:463\u2013475. https:\/\/doi.org\/10.1200\/JCO.2017.74.2270","journal-title":"J Clin Oncol"},{"key":"5697_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/cogs.12109","volume":"38","author":"AJ Schwartz","year":"2014","unstructured":"Schwartz AJ, Boduroglu A, Gutchess AH (2014) Cross-cultural differences in categorical memory errors. Cogn Sci 38:997\u20131007. https:\/\/doi.org\/10.1111\/cogs.12109","journal-title":"Cogn Sci"},{"key":"5697_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.dadm.2018.09.003","volume":"10","author":"SA Milani","year":"2018","unstructured":"Milani SA, Marsiske M, Cottler LB, Chen X, Striley CW (2018) Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity. Alzheimers Dement (Amst) 10:773\u2013781. https:\/\/doi.org\/10.1016\/j.dadm.2018.09.003","journal-title":"Alzheimers Dement (Amst)"},{"key":"5697_CR35","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/cncr.23375","volume":"112","author":"M Sorror","year":"2008","unstructured":"Sorror M, Storer B, Sandmaier BM, Maloney DG, Chauncey TR, Langston A, Maziarz RT, Pulsipher M, McSweeney PA, Storb R (2008) Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer 112:1992\u20132001. https:\/\/doi.org\/10.1002\/cncr.23375","journal-title":"Cancer"},{"key":"5697_CR36","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1002\/cncr.28323","volume":"119","author":"D Jones","year":"2013","unstructured":"Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS (2013) Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer 119:4188\u20134195. https:\/\/doi.org\/10.1002\/cncr.28323","journal-title":"Cancer"},{"key":"5697_CR37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.2013.54.2050","volume":"32","author":"JS Mandelblatt","year":"2014","unstructured":"Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A, Jacobsen PB, Faul LA, Isaacs C, Denduluri N, Gavett B, Traina TA, Johnson P, Silliman RA, Turner RS, Howard D, van Meter JW, Saykin A, Ahles T (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol 32:1909\u20131918. https:\/\/doi.org\/10.1200\/JCO.2013.54.2050","journal-title":"J Clin Oncol"},{"key":"5697_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/bmt.2008.211","volume":"42","author":"SJ Stagno","year":"2008","unstructured":"Stagno SJ, Busby K, Shapiro A, Kotz MM (2008) Patients at risk: addressing addiction in patients undergoing hematopoietic SCT. Bone Marrow Transplant 42:221\u2013226. https:\/\/doi.org\/10.1038\/bmt.2008.211","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.bmt.1705419","volume":"38","author":"F Hoodin","year":"2006","unstructured":"Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V (2006) Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 38:255\u2013264. https:\/\/doi.org\/10.1038\/sj.bmt.1705419","journal-title":"Bone Marrow Transplant"},{"key":"5697_CR40","first-page":"386","volume":"32","author":"JA Paice","year":"2018","unstructured":"Paice JA (2018) Navigating cancer pain management in the midst of the opioid epidemic. Oncology 32:386\u2013390","journal-title":"Oncology"},{"key":"5697_CR41","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/cncr.10889","volume":"95","author":"JR Fann","year":"2002","unstructured":"Fann JR, Roth-Roemer S, Burington BE, Katon WJ, Syrjala KL (2002) Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 95:1971\u20131981. https:\/\/doi.org\/10.1002\/cncr.10889","journal-title":"Cancer"},{"key":"5697_CR42","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1200\/JCO.2006.07.9079","volume":"25","author":"JR Fann","year":"2007","unstructured":"Fann JR, Alfano CM, Roth-Roemer S, Katon WJ, Syrjala KL (2007) Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol 25:1223\u20131231. https:\/\/doi.org\/10.1200\/JCO.2006.07.9079","journal-title":"J Clin Oncol"},{"key":"5697_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox J, Eurelings LS, de Jonghe JF et al (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. Jama 304:443\u2013451. https:\/\/doi.org\/10.1001\/jama.2010.1013","journal-title":"Jama"},{"key":"5697_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S1478951509990861","volume":"8","author":"T Wada","year":"2010","unstructured":"Wada T, Wada M, Wada M, Onishi H (2010) Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care 8:125\u2013131. https:\/\/doi.org\/10.1017\/S1478951509990861","journal-title":"Palliat Support Care"},{"key":"5697_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-050817-084903","volume":"14","author":"TA Ahles","year":"2018","unstructured":"Ahles TA, Root JC (2018) Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol 14:425\u2013451. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050817-084903","journal-title":"Annu Rev Clin Psychol"},{"key":"5697_CR46","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/pon.4351","volume":"26","author":"C Yao","year":"2017","unstructured":"Yao C, Rich JB, Tirona K, Bernstein LJ (2017) Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer. Psychooncology 26:2261\u20132268. https:\/\/doi.org\/10.1002\/pon.4351","journal-title":"Psychooncology"},{"key":"5697_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1017\/S1355617718000309","volume":"24","author":"B Collins","year":"2018","unstructured":"Collins B, Widmann G, Tasca GA (2018) Effectiveness of intraindividual variability in detecting subtle cognitive performance deficits in breast cancer patients. J Int Neuropsychol Soc 24:724\u2013734. https:\/\/doi.org\/10.1017\/S1355617718000309","journal-title":"J Int Neuropsychol Soc"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05697-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T23:07:19Z","timestamp":1629673639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05697-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,23]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05697-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,23]]},"assertion":[{"value":"16 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Wood receives funding from Pfizer for research not directly related to this work. Other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent for participation in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}